Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology

LGN de Almeida, H Thode, Y Eslambolchi… - Pharmacological …, 2022 - Elsevier
The first matrix metalloproteinase (MMP) was discovered in 1962 from the tail of a tadpole by
its ability to degrade collagen. As their name suggests, matrix metalloproteinases are …

[HTML][HTML] Glutamine metabolism in macrophages: a novel target for obesity/type 2 diabetes

W Ren, Y **a, S Chen, G Wu, FW Bazer, B Zhou… - Advances in …, 2019 - Elsevier
Obesity is a nutritional disorder resulting from a chronic imbalance between energy intake
and expenditure. This disease is characterized by inflammation in multiple cell types …

Local administration of regulatory T cells promotes tissue healing

B Nayer, JL Tan, YK Alshoubaki, YZ Lu… - Nature …, 2024 - nature.com
Regulatory T cells (Tregs) are crucial immune cells for tissue repair and regeneration.
However, their potential as a cell-based regenerative therapy is not yet fully understood …

Targeting the MCP‐GPX4/HMGB1 axis for effectively triggering immunogenic ferroptosis in pancreatic ductal adenocarcinoma

G Li, C Liao, J Chen, Z Wang, S Zhu, J Lai… - Advanced …, 2024 - Wiley Online Library
Induction of ferroptosis can inhibit cancer cells in vitro, however, the role of ferroptosis in
treatment in vivo is controversial. The immunosuppressive cells activated by the ferroptotic …

Interferon-γ in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells

Z **g, G Liu, N Zhou, D Xu, N Feng, Y Lei, L Ma… - Scientific reports, 2024 - nature.com
The bioactivity of interferon-γ (IFN-γ) in cancer cells in the tumor microenvironment (TME) is
not well understood in the current immunotherapy era. We found that IFN-γ has an …

Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn's disease

F Cordes, D Foell, JN Ding, G Varga… - World journal of …, 2020 - pmc.ncbi.nlm.nih.gov
In 2018, the pan-Janus kinase (JAK) inhibitor tofacitinib was launched for the treatment of
ulcerative colitis (UC). Although tofacitinib has proven efficacious in patients with active UC …

Th1, Th2, and Th17 cytokines in systemic lupus erythematosus

F Muhammad Yusoff, KK Wong, N Mohd Redzwan - Autoimmunity, 2020 - Taylor & Francis
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the
breakdown of immune tolerance leading to excessive inflammation and tissue damage …

[HTML][HTML] Macrophages in lupus nephritis: exploring a potential new therapeutic avenue

LE Kwant, Y Vegting, MWP Tsang-a-Sjoe… - Autoimmunity …, 2022 - Elsevier
Lupus nephritis (LN) is a serious complication of systemic lupus erythematosus (SLE) that
occurs in about half of patients. LN is characterized by glomerular deposition of immune …

The Regulatory Role of α‐Ketoglutarate Metabolism in Macrophages

S Liu, J Yang, Z Wu - Mediators of inflammation, 2021 - Wiley Online Library
Macrophages are multifunctional immune cells whose functions depend on polarizable
phenotypes and the microenvironment. Macrophages have two phenotypes, including the …

Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma

X Liang, H Gao, J **ao, S Han, J He, R Yuan… - Frontiers in …, 2023 - frontiersin.org
Background Indoleamine-2, 3-dioxygenase 1 (IDO1) is responsible for tumor immune
escape by regulating T cell-associated immune responses and promoting the activation of …